Literature DB >> 16829633

Interleukin-10 induces apoptosis in developing mast cells and macrophages.

Daniel P Bailey1, Mohit Kashyap, L Andrew Bouton, Peter J Murray, John J Ryan.   

Abstract

Interleukin (IL)-10 is a potent immunoregulatory cytokine capable of inhibiting the inflammatory response. As mast cells and macrophages are central effectors of inflammation, we investigated the effects of IL-10 on mast cell and macrophage development from mouse bone marrow progenitors. Bone marrow cells were cultured in IL-3 + stem cell factor (SCF), giving rise to mixed populations of mast cells and macrophages. The addition of IL-10 greatly decreased the expansion of bone marrow progenitor cells through a mechanism requiring signal tranducer and activator of transcription-3 expression. The inhibitory effects were a result of the induction of apoptosis, which occurred with caspase-3 activation and reduced mitochondrial membrane potential. Supporting a role for the mitochondrion, bone marrow cells from p53-deficient or Bcl-2 transgenic mice were partly resistant to the effects of IL-10. Further, IL-10 decreased Kit receptor expression and inhibited survival signaling by SCF or IL-3. These data indicate that IL-10 induces an intrinsic, mitochondrial apoptosis cascade in developing mast cells and macrophages through mechanisms involving blockade of growth factor receptor function. The ability of IL-10 to inhibit survival could support immune homeostasis by dampening inflammatory responses and preventing chronic inflammation.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16829633     DOI: 10.1189/jlb.0405201

Source DB:  PubMed          Journal:  J Leukoc Biol        ISSN: 0741-5400            Impact factor:   4.962


  21 in total

Review 1.  Mast cell homeostasis and the JAK-STAT pathway.

Authors:  J K Morales; Y T Falanga; A Depcrynski; J Fernando; J J Ryan
Journal:  Genes Immun       Date:  2010-06-10       Impact factor: 2.676

2.  IL-10 restricts dendritic cell (DC) growth at the monocyte-to-monocyte-derived DC interface by disrupting anti-apoptotic and cytoprotective autophagic molecular machinery.

Authors:  Carla Martin; Mel Pilar Espaillat; Frances Santiago-Schwarz
Journal:  Immunol Res       Date:  2015-12       Impact factor: 2.829

Review 3.  Molecular regulation of mast cell development and maturation.

Authors:  Chenxiong Liu; Zhigang Liu; Zhilong Li; Yaojiong Wu
Journal:  Mol Biol Rep       Date:  2009-07-31       Impact factor: 2.316

Review 4.  Potential effector and immunoregulatory functions of mast cells in mucosal immunity.

Authors:  L L Reber; R Sibilano; K Mukai; S J Galli
Journal:  Mucosal Immunol       Date:  2015-02-11       Impact factor: 7.313

5.  Intravenous vs intraperitoneal mesenchymal stem cells administration: what is the best route for treating experimental colitis?

Authors:  Fabiany da Costa Gonçalves; Natália Schneider; Fernanda Otesbelgue Pinto; Fabíola Schons Meyer; Fernanda Visioli; Bianca Pfaffenseller; Patrícia Luciana da Costa Lopez; Eduardo Pandolfi Passos; Elizabeth Obino Cirne-Lima; Luíse Meurer; Ana Helena Paz
Journal:  World J Gastroenterol       Date:  2014-12-28       Impact factor: 5.742

6.  Alterations in immune and renal biomarkers among workers occupationally exposed to low levels of trichloroethylene below current regulatory standards.

Authors:  Kyoung-Mu Lee; Luoping Zhang; Roel Vermeulen; Wei Hu; Bryan A Bassig; Jason Jj Wong; Chuangyi Qiu; Mark Purdue; Cuiju Wen; Douglas I Walker; Dean P Jones; Laiyu Li; Yongshun Huang; Nathaniel Rothman; Martyn T Smith; Qing Lan
Journal:  Occup Environ Med       Date:  2019-04-10       Impact factor: 4.402

7.  Occupational solvent exposure, genetic variation in immune genes, and the risk for non-Hodgkin lymphoma.

Authors:  Qian Deng; Tongzhang Zheng; Qing Lan; Yajia Lan; Theodore Holford; Yingtai Chen; Min Dai; Brian Leaderer; Peter Boyle; Stephen J Chanock; Nathaniel Rothman; Yawei Zhang
Journal:  Eur J Cancer Prev       Date:  2013-01       Impact factor: 2.497

Review 8.  Interleukin 10 in the tumor microenvironment: a target for anticancer immunotherapy.

Authors:  Takami Sato; Mizue Terai; Yutaka Tamura; Vitali Alexeev; Michael J Mastrangelo; Senthamil R Selvan
Journal:  Immunol Res       Date:  2011-12       Impact factor: 2.829

9.  Genetic polymorphisms, their allele combinations and IFN-beta treatment response in Irish multiple sclerosis patients.

Authors:  Catherine O'Doherty; Alexander Favorov; Shirley Heggarty; Colin Graham; Olga Favorova; Michael Ochs; Stanley Hawkins; Michael Hutchinson; Killian O'Rourke; Koen Vandenbroeck
Journal:  Pharmacogenomics       Date:  2009-07       Impact factor: 2.533

10.  Bone marrow findings in HIV-positive patients with Kaposi sarcoma herpesvirus-associated multicentric Castleman disease.

Authors:  Girish Venkataraman; Thomas S Uldrick; Karen Aleman; Deirdre O'Mahony; Donald S Karcher; Seth M Steinberg; Mark A Raffeld; Vickie Marshall; Denise Whitby; Richard F Little; Robert Yarchoan; Stefania Pittaluga; Irina Maric
Journal:  Am J Clin Pathol       Date:  2013-05       Impact factor: 2.493

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.